Oxford Pharmaceuticals Revenue and Competitors

Oxford’s mission is to manufacture, package and distribute affordable, high quality generic drug products to improve the lives of patients. Oxford owns multitude of ANDAs which are currently being manufactured, packaged, then put on stability under a stringent validation program. Oxford expects to file initial products for commercial approval by early summer 2018. Oxford also intends to act as a CMO or CPO once its systems are validated and procuring required approvals. Oxford prides itself in making drugs right here in the USA! Oxford aims to be a market leader in generics once its start-up, validation and testing phases are complete. Oxford has multiple equipment to produce tablets, capsules. It has state of the art manufacturing facility capable of handling compression, granluation, film coating using equipment like Vector, Kikusui and Accela Cota. Oxford has 1 fully operational and validated high speed packaging line equipped with serialization capability from Optel and Tracelink. A 2nd dual filler line is installed and is undergoing trials. The Quality Control lab is fully functional with the latest testing equipment like HPLCs, UPLCs, GCs and microbial testing sub lab. There are also two warehouses with vaults to manage controlled substances. The company also boasts of biometric based security and doorways, pressured rooms and hallways and a high purity water system to meet pharmaceutical needs. During our start-up phase, Oxford is also focussing on contract packaging opportunities, currently serving many virtual companies. We are excited on our journey and we encourage to get in touch with us for any needs that we may be able to fulfil.